GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuji Pharma Co Ltd (TSE:4554) » Definitions » Gross Profit

Fuji Pharma Co (TSE:4554) Gross Profit : 円17,124 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuji Pharma Co Gross Profit?

Fuji Pharma Co's gross profit for the three months ended in Mar. 2024 was 円4,681 Mil. Fuji Pharma Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was 円17,124 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Fuji Pharma Co's gross profit for the three months ended in Mar. 2024 was 円4,681 Mil. Fuji Pharma Co's Revenue for the three months ended in Mar. 2024 was 円10,642 Mil. Therefore, Fuji Pharma Co's Gross Margin % for the quarter that ended in Mar. 2024 was 43.99%.

Fuji Pharma Co had a gross margin of 43.99% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Fuji Pharma Co was 44.01%. The lowest was 39.55%. And the median was 41.83%.

Warning Sign:

Fuji Pharma Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.1%.


Fuji Pharma Co Gross Profit Historical Data

The historical data trend for Fuji Pharma Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuji Pharma Co Gross Profit Chart

Fuji Pharma Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,796.00 14,872.00 14,751.00 14,558.00 16,514.00

Fuji Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,589.00 3,903.00 4,988.00 3,552.00 4,681.00

Competitive Comparison of Fuji Pharma Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuji Pharma Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's Gross Profit falls into.



Fuji Pharma Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Fuji Pharma Co's Gross Profit for the fiscal year that ended in Sep. 2023 is calculated as

Gross Profit (A: Sep. 2023 )=Revenue - Cost of Goods Sold
=40889 - 24375
=16,514

Fuji Pharma Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=10642 - 5961
=4,681

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円17,124 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Fuji Pharma Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=4,681 / 10642
=43.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fuji Pharma Co  (TSE:4554) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fuji Pharma Co had a gross margin of 43.99% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Fuji Pharma Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Fuji Pharma Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuji Pharma Co (TSE:4554) Business Description

Traded in Other Exchanges
Address
5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co.,Ltd. is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Fuji Pharma Co (TSE:4554) Headlines

No Headlines